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Dystroglycan (DG) is an adhesion complex that links the cytoskeleton to the surrounding
extracellular matrix in skeletal muscle and awide variety of other tissues. It is composed of
a highly glycosylated extracellular α-DG associated noncovalently with a transmembrane
β-DG whose cytodomain interacts with dystrophin and its isoforms. Alpha-dystroglycan
(α-DG) binds tightly and in a calcium-dependent fashion to multiple extracellular proteins
and proteoglycans, each of which harbors at least one, or, more frequently, tandem arrays
of laminin-globular (LG) domains. Considerable biochemical and structural work has
accumulated on the α-DG-binding LG domains, highlighting a significant heterogeneity
in ligand-binding properties of domains from different proteins as well as between single
andmultiple LG domains within the same protein. Here we review biochemical, structural,
and functional information on the LG domains reported to bind α-dystroglycan. In
addition, we have incorporated bioinformatics and modeling to explore whether specific
motifs responsible for α-dystroglycan recognition can be identified within isolated LG
domains. In particular, we analyzed the LG domains of slits and agrin as well as those
of paradigmatic α-DG non-binders such as laminin-α3. While some stretches of basic
residues may be important, no universally conserved motifs could be identified. However,
the data confirm that the coordinated calcium atom within the LG domain is needed to
establish an interaction with the sugars of α-DG, although it appears that this alone is
insufficient to mediate significant α-DG binding. We develop a scenario involving different
binding modes of a single LG domain unit, or tandemly repeated units, with α-DG. A
variability of binding modes might be important to generate a range of affinities to allow
physiological regulation of this interaction, reflecting its crucial biological importance.
Keywords: dystroglycan, laminin globular (LG) domains, binding affinities, protein modeling, protein structure
INTRODUCTION
In the tissues of multicellular animals, different cell types establish intercellular molecular contacts
(junctions) as well as cellular-extracellular ones. Accordingly, connections established between
the extracellular matrix (ECM) and appropriate adhesion complexes at the cell surface support
the functional morphology and physiology of different tissues during development and in adult
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animals. A well-conserved array of ECM proteins, cell adhesion
receptors and ECM proteases has been identified in animals
(Özbek et al., 2010; Hynes, 2012). In this context, dystroglycan
is probably the major non-integrin adhesion complex for the
formation of molecular contacts that stabilize the interface
between cell membranes in skeletal muscle and the specialized
ECM surrounding them (i.e., basement membranes) (Adams and
Brancaccio, 2015) (see Figure 1A).
Dystroglycan (DG) is composed of two subunits, α-DG which
is extracellular and highly glycosylated, and the transmembrane
β-DG, whose cytoplasmic domain links the whole adhesion
complex to dystrophin and the actin cytoskeleton in skeletal
muscle. In addition to skeletal and cardiac muscles, DG has
a wide tissue distribution and interacts with utrophin and
dystrophin isoforms within the cytoplasm in a variety of tissues,
such as the central and peripheral nervous system, lung and
kidney (Barresi and Campbell, 2006).
In striking contrast with the integrin family of cell-ECM
adhesion receptors, there is only one DG gene (DAG1), and no
physiologically relevant alternative splicing has been reported
so far. Therefore, different α-DG binding affinities for various
extracellular ligands seem to depend on the degree of α-DG
glycosylation, which might vary in different tissues (McDearmon
et al., 2006; Sciandra et al., 2013). In fact, α-DG interacts
with members of the laminin family of ECM glycoproteins and
several other ECM-associated binding partners through its ability
to recognize the so-called laminin-globular (LG) domains (see
Figure 1B for a summary of the domain architecture of the
binding proteins discussed here). LG domains were originally
identified within laminins (Beck et al., 1990) but can be found
in several proteins and proteoglycans located in the ECM as well
as in a variety of otherwise diverse proteins (Talts et al., 1998).
The LG domains that bind α-DG likely represent a distinct subset
within the entire LG-domain family and are expected to share
common structural features that allow them to recognize α-DG.
However, sequence analysis demonstrates a limited degree of
homology amongst different LG domains, and it is possible that
other members of the LG domain family remain to be identified
(Rudenko et al., 2001).
Although other proteins and proteoglycans harboring LG
domains (for example, thrombospondins, Adams and Lawler,
2011) might be additional α-DG binders, the focus of this Review
is on the established and physiologically relevant molecular
partners whose binding behaviors have been tested both in
vivo and in vitro. We examine LG domains demonstrated
experimentally to bind α-DG for potential common structural
features and compare these domains with LG domains that do
not bind α-DG in vitro.
Laminins and certain other LG-containing binding partners
have high, or very high (Kd’s within the low nanomolar range)
binding affinities for α-DG (Sciandra et al., 2013). The interaction
depends on recognition of O-linked sugar moieties that protrude
from the central mucin-like domain of α-DG. Multiple analyses
from different groups have led to an increased understanding
of the glycosylation moieties of O-mannosylated α-dystroglycan,
whose complex structure also includes ribitol-phosphate, a newly
identified glycosylation unit in mammals (for further details see
recent reviews by Manya and Endo, 2017; Sheikh et al., 2017;
Kanagawa and Toda, 2018).
Like legume lectins as well as animal galectins, with which
they share a similar fold (Rudenko et al., 2001), the LG
domains establish crucial protein-sugar interactions to stabilize
sarcolemma and other plasma membranes. In this regard, it has
recently been shown (Briggs et al., 2016) that the recombinant
LG4-LG5 pair of murine laminin-α2 can be crystallized in
combination with a polysaccharide that is found in α-DG and
belongs to its glycan-repeated scaffold (Willer et al., 2014);
this important study also demonstrates the crucial role of
a coordinated calcium cation for binding. The disaccharide
portion of the sugar molecule identified in the structure is
coordinated only to the LG4 domain (Briggs et al., 2016), and
any additional contribution of protein-protein interactions in the
DG/LG binding, possibly involving portions of the core protein
of DG, has not so far been confirmed (Bozic et al., 2004). A point
of curiosity is that, while many LG-containing proteins include
multiple LG domains, a few, such as the slits, contain only a single
domain. It is not clear whether this distinction reflects a different
mode of binding.
Although in the past 20 years considerable biochemical and
structural data (see Table 1) have been collected on laminins (the
prototypical LG-containing DG binding partners) and on several
other DG binding partners, several key questions concerning
dystroglycan-LG binding remain unanswered. For example, is it
possible to identify common molecular characteristics (ideally
short linear motifs) that would define the propensity to bind
α-DG in this domain family? On the other hand, are there
some identifiable structural features shared by non-binding
LG-domains? These questions could have important biological
implications, and to review them we have combined two separate
lines of analysis. Firstly, we consider the general features of
LG domains and re-evaluate the available information on the
interaction of α-dystroglycan to its binding partners that share
LG domains; secondly, we have carried out homology modeling
of LG domains of unknown structure, with a specific focus on
two paradigmatic cases, namely the LG domains of human slit
and agrin. The modeling results are reported in the paragraphs
corresponding to the different binding partners of DG in the
sections below, and the methods employed are described in the
section “Methods for sequence analysis and homology modeling”
of the Supplementary Material.
GENERAL FEATURES OF LG DOMAINS
LG domains have a globular/spherical shape and are commonly
composed of 160–180 amino acids, mostly organized as a jelly-
roll sandwich with two antiparallel seven-stranded β sheets
(Timpl et al., 2000; Le et al., 2011). For example, the structure
of human perlecan LG3 has been solved both in calcium-bound
(PDB: 3SH5) and apo form (PDB: 3SH4) (Le et al., 2011),
and comprises 14 β-strands (from A to N) and 2 α-helices
(Figure 2). The specific β-strand order, as found in perlecan
LG3, JIHCLAN and GFEDKBM (in the two opposing β-sheets,
respectively, see Figure 2) applies broadly to all the LG domains
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FIGURE 1 | (A) The dystrophin-glycoprotein complex (DGC). Dystroglycan is embedded within the membrane as a pivotal member of the complex establishing
multiple contacts with extracellular, transmembrane, and intracellular partners. In skeletal muscle it creates a “molecular bridge” between cells and the surrounding
tissues offering stability upon muscle contraction. (B) Domain architecture of representative α-dystroglycan binding partners. LG domains representing α-DG-binding
sites are boxed in green. Each domain has been assessed using InterProScan 5.2 (https://www.ebi.ac.uk/interpro/) database as described in the Supplementary
section. Codes: LN-N-term. (Laminin, N-terminal), LN-EGF (Laminin-type epidermal growth factor-like), LN IV (Laminin IV domain), LNαDI (Laminin alpha, domain I),
LNDII (Laminin Domain II), NtA (N-terminal of agrin), SEA (Sperm protein, Enterokinase and Agrin), EGF-like (Epidermal growth factor-like), IG-like
(Immunoglobulin-like), Leu-r (leucine-rich), Cys-r (cysteine-rich). Not to scale.
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whose 3D structures have been resolved, although in some case
the strands at the edges of the sheets are not well-defined. Thus,
human perlecan LG3 structure is used as a reference in this
Review, that mainly focuses on human LG domains. It should
be noted that the two α-helices following the B and K strand in
perlecan LG3 are not uniformly found in other LG domains of
known structure.
The conserved Ca2+ coordination site in LG domains of
known structure comprises side chain (acidic or amide) and
backbone carbonyl groups on three loops that come together
on one edge of the “clam”-like LG domain, namely the
loops between β-strands D-E, F-G, and J-K (see Figures 2,
3). In more detail these are (i) a highly conserved acidic
side chain (usually Asp but occasionally Glu) on the D-E
loop, (ii) a backbone carbonyl group on the F-G loop, and
(iii) a backbone carbonyl and a side chain acidic or amide
group on the long J-K loop. Water molecules likely provide
two hydrogen bonds to fully coordinate the Ca2+ ion, and
the recently resolved crystal structure of laminin-α2 LG4 in
the presence of a co-crystallized α-DG polysaccharide (Briggs
et al., 2016) indicates that these waters are displaced by Ca2+-
coordinating oxygen atoms on the carbohydrate, presumably
when an LG domain undergoes Ca2+-dependent binding. The
structure reported by Briggs et al. also shows that in addition
to coordinating the LG domain Ca2+ ion, the disaccharide
moiety interacts directly with the laminin α2 LG4 domain
through an interesting stacking interaction between R2803 and
the GlcA1 ring, and via hydrogen bonds between backbone amide
NH groups (D2873 and I2874) with the GlcA3 ring carboxyl
group and between the backbone carbonyl of G2826 and GlcA1
ring hydroxyl group (Figure 3A). Although the carbohydrate-
stacking arginine of laminin α2 LG4 is not conserved amongst LG
domains (see Figure S1), backbone amide groups in equivalent
hydrogen-bonding positions, and especially a highly conserved
glycine equivalent to G2826 (see Figure 3B and Table 2) may
provide common interaction points for LG domains that
bind α-dystroglycan.
STRUCTURAL ANALYSIS AND MODELING
OF DIFFERENT α-DG BINDING
LG DOMAINS
Table 1 summarizes key properties of LG domains present in
proteins and proteoglycans that are known to bind α-DG and
which are discussed in detail below. Particular emphasis is given
to the LG-domains that bind as isolated single domains or as a
tandem array. In some cases (e.g., laminin-α3-containing laminin
isoforms), the possibility of α-DG binding has not been tested
yet, although sequence homologies with domains having known
structures allows these to be modeled and inferences made about
their likely Ca2+ and α-DG binding.
Laminins
Laminins are hetero-trimers composed of single α, β, and
γ chains. They represent the most extensively biochemically
characterized family of α-DG binding partners. In fact, laminin-
globular (LG) domains are named after the five domains
commonly found at the C-terminal portion of all laminin α
chains, typically separated by short stretches of linking amino
acids (Beck et al., 1990; Timpl et al., 2000). Extensive binding
analysis (Andac et al., 1999; Talts et al., 1999, 2000) as well
as crystallization and X-ray structural analysis, carried out by
Hohenester and colleagues (Hohenester et al., 1999; Tisi et al.,
2000; Harrison et al., 2007; Carafoli et al., 2009) on several
laminin LG domains expressed recombinantly, suggests the
presence of a hierarchy of binding modes and affinities (see
Table 1). Affinity studies have shown that the presence of tandem
arrays seems to be required for efficient binding to DG (e.g., two
domains as in LG4–5, or three as in LG1–3); in only a few cases
can binding be supported by an isolated LG domain. Examples
of the latter are LG4 of the laminin α1 chain (probably the most
efficient binder) (Durbeej et al., 2001) or, with reduced affinity,
LG3 of α2 or LG4 of α5 (see Figure 4).
From the viewpoint of function, the terminal LG domains
seem to represent a binding hot-spot. For example, it has been
observed that binding of LG4-5 of laminin α1 induces tyrosine
phosphorylation of syntrophin, initiating a signaling pathway
(Zhou et al., 2006). In a similar line of enquiry, the functional
role of a specific stretch of residues spanning the loop which
connects the adjacent E and F β-strands of the LG4 module and
is important for syndecan and heparin binding in laminin-332
(Utani et al., 2001), has been analyzed in all the five isoforms
of murine laminin α via a panel of synthetic peptides (Suzuki
et al., 2003). The analysis suggested that this region is involved in
several biological activities, including cell attachment and neurite
outgrowth, although α-DG binding was not tested (Suzuki et al.,
2003). The latter observation is consistent with the position of
this loop at the opposite side of the LG domains from the Ca2+
and carbohydrate binding regions that are involved in α-DG
binding (see Figure 2).
As far as calcium is concerned, it is generally accepted that
this metal is required to achieve tight α-DG binding (Ervasti
and Campbell, 1993; Brancaccio et al., 1995). In fact, a calcium
ion must be bound to LG4, but not LG5, for efficient binding
of murine laminin-α2 to α-DG (Wizemann et al., 2003), and,
more recently, the importance of Ca2+ in LG4 of murine laminin
α1 for chelating disaccharide units present on α-DG has been
demonstrated (Briggs et al., 2016). Underscoring the importance
of Ca2+ for α-DG binding, crystal structures of a number of LG
domains have been solved that contain a Ca2+ (or Mg2+) ion
within a structurally homologous binding site. These include LG
domains of agrin, laminins, neurexins, and perlecan (Figure 5A).
The Ca2+ site of LG domains is a weak site with just two
(laminins; agrin) or one (neurexins; perlecan; slits) negatively-
charged side chains involved in chelating the metal ion (Table 2).
The relatively weak binding affinity of LG domains for Ca2+
is consistent with a matching of Ca2+-binding affinity to the
physiological calcium concentration in the extracellular milieu,
which is in the low millimolar range (Hofer and Brown, 2003).
Based on sequence analysis, it has been suggested that laminin
α3, α4, and α5 chains would not bind calcium (Timpl et al.,
2000). It has been shown, however, that EDTA does abolish
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FIGURE 2 | Crystal structure of perlecan LG3 domain. β-strands are annotated according to the scheme of Le et al. (2011). In this representation (A) strands M and N
are “fused” and a short sequence in the D-E loop is missing density in the crystal structure. The Ca2+ ion in the perlecan LG3 Ca2+ binding site (ligand residues are
highlighted) is shown as a sphere. (B) homology model of a slit-2 LG domain constructed on the perlecan LG3 structure template. The slit-2 model produces a
potential Ca2+-binding domain with a very similar arrangement of backbone and side chain ligands for Ca2+ as in the LG3 domain, suggesting that the slit-2 LG
domain is likely to bind Ca2+. See Figure 8 for additional interpretation of slit LG domain homology models.
FIGURE 3 | (A) Structure of laminin-α2 LG4 cocrystallised with a LARGE polysaccharide moiety. LG domain side chain and backbone carbonyl ligands coordinating
the Ca2+ ion are identified with black bold and italic annotations, respectively. LG domain groups making direct interaction with the carbohydrate are identified with
blue annotations; these are: R2803 side chain stacking with the Xyl2 ring; G2826 backbone carbonyl with a GlcA1 ring hydroxyl group and D2783 and I2874
backbone amide NH groups with the GlcA3 carboxyl. The two carbohydrate oxygen atoms coordinating the Ca2+ ion are identified with red stars (Briggs et al., 2016),
PDB:5IK5. (B) Structure of perlecan overlaid with the disaccharide unit shown in (A). To construct the model in (B) the perlecan LG (PDB:3SH5) and laminin-α2 LG4
domains were superimposed, and the disaccharide from laminin-α2 directly extracted onto perlecan. Apart from a small difference in the positions of the Ca2+ ions in
the two structures, the disaccharide “fits” into the perlecan structure and provides equivalent Ca2+ coordinating ligands as in the laminin-α2 LG4 structure. Equivalent
groups providing potential hydrogen bonds with carbohydrate (G4276; V4324; A4325) are annotated in blue. The similarities suggest that perlecan should coordinate
carbohydrate units of α-DG in a manner similar to that of laminin-α2 LG4.
binding of α-DG to both a laminin-α5 LG domain fragment
(including LG1 to LG5) expressed in bacteria and labeled with
biotin (Shimizu et al., 1999), and to α5-containing laminin (Yu
and Talts, 2003) or laminin-α5 and specific deletion mutants
recombinantly expressed in eukaryotic cells (Ido et al., 2004).
Homology models obtained here suggest that weak Ca2+ binding
sites might be formed from non-canonical arrangements of
candidate Ca2+ ligands (Figure 4), potentially explaining the
effects of EDTA on α-DG binding to laminin-α5 LG domain
fragments. Laminin-α3 is likely to represent a paradigmatic α-
DG non-binder (Ferletta et al., 2003; Kikkawa et al., 2004).
In fact, the nature of potential cell-surface laminin-α3 binders
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TABLE 2 | Amino acid ligands for Ca2+ in X-ray structures and modeled LG domains.
LG domain and
PDB
D–E loop F–G loop J–K loop Species and NCBI
accession codes
Laminin α1 LG4
2JD4 (Mg2+)
NQMD2771YAT FMFDL2788GKGR GK
aATT2838LD2840VERK Mus musculus P19137
Laminin α2 LG4
5IK5 (Ca2+)
NHAD2808FATV FSYDL2825GSGD KKADI2874LD2876VV Mus musculus Q60675
Laminin α2 LG5
1QU0 (Ca2+)
QKMD2982GMG MFHVDN2999GAG SASTS3053AD3055TNDP Mus musculus Q60675
Laminin α3 LG4
model on 2JD4
– FALGT3050D3051GKKLR LPGNS3098T3099 ISIR Homo sapiens Q16787
Laminin α5 LG3
model on 2JD4
RASPD3169GLCQ – PPPE3233LQ3235PQP Homo sapiens O15230
Laminin α5 LG4
model on 2JD4
VAQM3405E3406GLGT – HQGAE3460HPQP Homo sapiens O15230
Agrin LG3
1PZ7,1PZ8 (Ca2+)
1PZ9 (Ca2+ -free)
GLERSD1953YIALA MMYDL1970GSKP LGATQ2020LD2022TD Gallus gallus P31696
Perlecan LG3
3SH5 (Ca2+)
3SH4 (Ca2+-free)
GVEVGEAGQGKD4258FISL VFRYQL4275GSGEAR PGPN4323VA4325VN4327AKGS Homo sapiens P98160
Neurexin 1α LG2
2H0B (Ca2+)
GKSAD329YVN SLVINL346GGSGAF EDYTM414LGSDD Bos taurus XP_010808206
Neurexin 1β LG1
2R1D (Ca2+)
SGLGD137YLE VKFNV154GTDD GRQLTI236FN238SQAT Rattus norvegicus Q63373
Slit-1 LG1
model on 2JD4
GDND1210HIAV VSYDP1227GSYP GKHYT1278LNSEA Homo sapiens O75093
Slit-2 LG1
model on 1QU0
and 2JD4
GDKD1204HIA ASYDT1221GSHP NLSKQ1270ST1272LN1274F Homo sapiens O94813
Slit-3 LG1
model on 2JD4
KGDND1209PLA VYDS1226L1227SSPP QKQPA1277VGIN Homo sapiens
NP_001258875
aK is reported as a N in the NCBI sequence: a mutation introduced to eliminate N-glycosylation. Amino acids in bold and italics provide side chain (carboxyl, amide or hydroxyl) or
backbone carbonyl Ca2+ liganding groups in the observed or modeled Ca2+ binding sites. The highly conserved glycine residue that follows the Ca2+ liganding group in the F-G loop
of many LG domains is underlined.
with roles in cell adhesions are unknown. A synthetic peptide
based on the murine laminin-α3 sequence that spans the loop
connecting the two adjacent E and F β-strands (within its LG4
module) does not affect cell attachment (Suzuki et al., 2003),
whereas the human-based peptide does (Yokoyama et al., 2005).
However, the terminal LG4-5 domains of laminin-α3 can bind
syndecan 1 and 4 (Utani et al., 2001; Carulli et al., 2012).
Homology modeling of laminin-α3 LG domains presented here
(Figure 5B) supports the conclusion that these domains are
unlikely to bind Ca2+. We propose that this may contribute to
low α-DG affinities.
Agrin
Neuronal agrin is a heparan sulfate proteoglycan secreted
presynaptically which plays an important role in the maturation
and stability of the postsynaptic element at the neuromuscular
junction (NMJ) (Ruegg and Bixby, 1998). It harbors three LG
domains within its C-terminal region, and analysis of isolated
domains produced recombinantly showed that the first two (LG1
and LG2) are sufficient for DG binding whereas the last one,
LG3 (whose structure has been solved, Stetefeld et al., 2004),
lacks or shows very weak binding to α-DG yet is sufficient in
isolation for the maturation of the NMJ (Gesemann et al., 1996).
In addition, NMR studies have shown that the LG3 domain
of agrin binds sialic acid in a Ca2+-dependent manner, whilst
binding the glycosaminoglycans heparin and heparan sulfate
bind independently of Ca2+. It remains unclear whether these
observations may be relevant for α-dystroglycan binding to agrin
(Sallum et al., 2007).
The LG domains of agrin are separated by EGF-like modules.
Interestingly, a splice variant that includes an inserted basic
stretch of residues (site A: KSRK) in the loop between the J
and K strands, which introduces a heparin binding site within
its LG2 domain, binds α-DG less efficiently (Campanelli et al.,
1996; Gesemann et al., 1996; O’Toole et al., 1996). The homology
models of agrin LG2 in Figure 6 show that the basic site A
sequence (KSRK) likely lies adjacent to a putative Ca2+ binding
site spatially homologous to the Ca2+ sites in LG domains of
known structure, such as perlecan (see Figures 2, 6). Additional
agrin splicing isoforms of different lengths (0, 8, 11, or 19 a.a.),
involve a site (B) located between the last EGF-like module
and the final LG3 domain. The agrin isoform A0B0 (expressed
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FIGURE 4 | Homology models of laminin LG domains. Laminin-α5 LG3 (A) and laminin-α5 LG4 (C) built on the crystal structure template of murine laminin-α1 LG4
(B, PDB:2JD4, NCBI Code: P19137). Neither the LG3 nor the LG4 domain of laminin-α5 has a canonical Ca2+ binding site. However, each of the laminin-α5 LG
domain models places potential Ca2+ chelating ligands near the expected position of a Ca2+ ion. Conformational flexibility in the loops on the edge of these domains
may allow weak Ca2+ binding that could explain observations of EDTA attenuation of α-DG binding by laminin-α5. The laminin-α5 LG4 model has a basic patch (RHR)
in a topologically-equivalent location on the B-C loop as other basic patches of other known α-DG-binding LG domains including laminin-α1 LG4 (middle). Note that
2JD4 is the murine laminin-α1 LG4 structure; the human laminin-α1 LG4 equivalent has RKK rather than RKR in this basic patch motif. In red: residues involved in
Ca2+ binding (italic numbers denote backbone carbonyl ligands), in purple: Arg residues of the basic patch.
by skeletal muscle cells) shows the tightest binding to α-DG
(Gesemann et al., 1996, 1998).
Several missense mutations (reported in green in Figure S1),
mostly homozygous, have been identified in LG domains of agrin
(Huzé et al., 2009; Maselli et al., 2012; Karakaya et al., 2017; Xi
et al., 2017; Zhang et al., 2017); these are located in β-strands or
inter-strand loops that may be involved in α-DG binding. The
missense mutations that cause congenital myasthenic syndrome
(CMS) affect the agrin LG2 domain (namely, G1675S, R1698C,
G1709R, V1727F, and A1768P), which is known to be part of the
α-DG binding site together with LG1 (Gesemann et al., 1996).
The extent to which these mutations might affect α-DG binding
and how the agrin/α-DG connection would relate to the range
of CMS phenotypes have yet to be determined. For example, an
instability of agrin and impaired clustering of the acetylcholine
receptor (AChR) has been observed in cells containing the
R1698C mutant (Xi et al., 2017), which, according to our model,
is expected to lie on the E-F loop on the opposite side of the
domain to the Ca2+ coordination site. The neighboring G1709R
that lies on the FG loop near the Ca2+ site was not reported to
affect α-DG binding (Huzé et al., 2009). The structural context
of these mutations is illustrated on the model of human agrin
LG2 in Figure 7.
Perlecan
Another heparan sulfate proteoglycan which binds α-DG tightly
(Friedrich et al., 1999; i.e., with Kd within the low nanomolar
range, Talts et al., 1999) is perlecan. The C-terminal portion of
perlecan is termed domain V and includes three LG domains
and several EGF-like domains organized in the following order:
LG1-EG1-EG2-LG2-EG3-EG4-LG3. The recombinant domain
V, which includes all the LG domains (LG1-3), shows the
tightest binding to α-DG, but LG1-2 and LG2-3 pairs can
also bind; conversely, isolated perlecan LG domains did not
bind in the range of ligand concentrations explored (i.e.,
up to 500 nM) (Friedrich et al., 1999). Perlecan domain V,
renamed “endorepellin” due to its angiostatic activity (Gonzalez
et al., 2005), has been involved in multiple biological functions
related to its ability to modulate cytoskeletal dynamics in
a calcium-dependent manner (Le et al., 2011). The high-
resolution crystal structure of human perlecan LG3 has been
solved (see Figures 2, 4A) and the presence of a Ca2+ ion
confirmed, highlighting some structural similarities with other
LG domains (namely, LG3 of agrin, LG2 of neurexin1α, LG5
of laminin-α2 and LG1 of neurexin1β) (Le et al., 2011). A
superposition of the perlecan LG domain structure with the
structure of laminin-α2 LG4 that contains a co-crystallized
polysaccharide unit (Briggs et al., 2016) indicates that the α-
DG binding edge of the perlecan LG domain is likely to
bind disaccharide units in a similar fashion to that of laminin
LG4 (Figure 3).
Pikachurin
Pikachurin is a retinal ECM protein localized to the synaptic
cleft in the photoreceptor ribbon synapse of the central nervous
system, which binds α-DG in a Ca2+-dependent fashion (Sato
et al., 2008). Within its C-terminal portion, pikachurin harbors
three LG domains separated by single EGF-like domains. Binding
experiments on recombinantly produced isolated domains have
shown that LG2-3 are sufficient for binding with an affinity
similar to LG1-3 (Kanagawa et al., 2010). This implicates
pikachurin LG1 as another LG domain that could be included
within the group of “non-binders” (see below). LG3 alone is
unable to induce DG clustering (Omori et al., 2012), indicating
that a tandem array (doublet) of LG domains is required
for binding.
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FIGURE 5 | (A) Comparison of the Ca2+ binding site in Ca2+-bound (green)
and Ca2+-free (blue) perlecan. Ca2+-bound perlecan PDB:3SH5; Ca2+-free
perlecan PDB:3SH4. The structure of the binding site is maintained in the
absence of Ca2+. Similar observations have been made with agrin in its free
and Ca2+ - bound states (Stetefeld et al., 2004). The Ca2+ ligands are
highlighted; italic type denotes backbone carbonyl ligands. (B) Homology
model of laminin-α3 LG4. The model was built on the crystal structure template
of laminin-α1 LG4 (PDB:2JD4). This domain lacks potential Ca2+-chelating
acidic or amide groups on the D-E and J-K loops (see residues labeled in red);
the side chain carboxyl (D3051) on the F-G loop is poorly positioned to chelate
Ca2+. This domain is predicted to have a very weak Ca2+ binding site.
Neurexins
Neurexins are neuron-specific cell surface proteins expressed at
the presynaptic terminal, that bind neuronal α-DG (Sugita et al.,
2001; Südhof, 2008). For an overview of the role of neurexins in
synaptic organization the reader is referred to a recent review
(Rudenko, 2017). In humans, there are three paralogous genes
coding for neurexins 1, 2, and 3. Most of the work concerning the
neurexin-DG axis has been carried out on neurexin1. Typically,
the gene has two promoters: α (upstream) and β (downstream),
encoding longer neurexins-α and shorter neurexins-β, each
harboring LG domains within their extracellular portions. In
neurexin-1, the LG domains of neurexin-α are organized with
interspersed EGF-like domains as follows: LG1-EGF1-LG2-
LG3-EGF2-LG4-LG5-EGF3-LG6 (see Figure 1B). Neurexin-β
features only one LG domain. Interestingly, an extensive analysis
of recombinant isolated domains showed that only LG2 and
LG6 of neurexin1α and LG1 of neurexin1β (identical to LG6
of neurexins-α) could bind α-DG tightly and, most relevantly,
in an isolated fashion. There is a plethora of neurexin splicing
isoforms (Missler et al., 1998), and the forms with no inserts
appear to bind better to α-DG (Sugita et al., 2001). A large
body of structural work on neurexin-1 has been carried out by
Rudenko and coworkers (Rudenko et al., 1999; Sheckler et al.,
2006; Shen et al., 2008; Chen et al., 2011), showing that their
LG domains conform to the typical jelly-roll fold motif and
revealing unexpected structural similarity to legume lectins and
human galectins (Rudenko et al., 1999). In fact, it has been
suggested that neurexins might bind carbohydrates, and that
this could have a role in the interaction with DG. In addition,
neurexins bind tightly to other protein partners such as α-
latrotoxin and neuroligin, and alternative splicing also modulates
such binding activities (Rudenko et al., 1999). It has been shown
that LG2 of neurexin1α binds calcium with Kd ≈ 400µM, and
that splicing may influence the affinity (Sheckler et al., 2006).
Similarly, splicing was also shown to modulate the affinity for
calcium of the LG domain of neurexin1β (Shen et al., 2008).
However, it remains unclear how this effect may relate to α-
DG binding. Interestingly, binding of α-DG and neurexophilin-
1 to neurexin1α are mutually exclusive, suggesting overlapping
binding epitopes, and that the binding of α-DG to neurexin
can also influence the formation of trans-synaptic neurexin-
neuroligin complexes (Reissner et al., 2014).
Slits
Slit-2 is another neuronal protein that acts as a secreted axonal
cue guidance factor and is reported to bind α-DG (Wright
et al., 2012). Slit-2 is the only binding partner of α-DG that
has a single LG domain (the other one, neurexin1β, being a
cell surface receptor; see above). Although the binding constant
has not been determined, it would be predicted to bind α-DG
tightly. It has been shown that a pair of basic residues (in the
sequence KVR) is important for DG binding, as is the presence
of a coordinated calcium ion (Wright et al., 2012). There are
two additional highly homologous slit paralogs, known as slit-1
(in which the KVR is not conserved) and slit-3 (in which it is),
however there are no reports on their potential α-DG binding
properties as yet.
Homology models of the LG domains of the slits (Figure 8)
support the presence of a canonical Ca2+ site in slit-2, with
an arrangement of potential Ca2+-chelating groups that is
similar to that of the structurally-defined Ca2+ site of perlecan
(see Figure 2, with the model of slit-2 on the right for
comparison); the latter binds Ca2+ with a Kd ≈ 100µM
(Le et al., 2011).
The KVR sequence required for tight binding of α-DG in slit-
2 lies on the same edge of the domain as the Ca2+ site (Figure 8)
and likely occupies a structurally equivalent position on the B-
C strand loop as the corresponding RKK sequence of human
laminin-α1 LG4 (RKR in murine laminin-α1 LG4; Figure 4) and
the RHR sequence of laminin-α5 LG4 (Figure 4). We speculate
that this basic “patch” may serve as an additional site for the
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FIGURE 6 | Homology models of agrin LG2 KSRK-containing splice variant. Models were obtained using as template: (A) human perlecan LG3 (3SH5), (B) chicken
agrin LG3 (1PZ7) and (C) murine laminin-α1 LG4 (2JD4). The potential Ca2+ binding site is relatively well defined and independent of the structural template. The
Ca2+ ions modeled into the putative Ca2+ binding sites are shown as spheres. The position of the KSRK sequence (green) that lies in the loop between the J and K
strands (see text) is not well-constrained in the models. These models illustrate the variability in structures of modeled LG domains obtained when using a range of
different structural templates. Note that the strongest sequence homology (≈35% identity) is between human agrin LG2 and perlecan LG3.
FIGURE 7 | Homology model of human agrin LG2 showing the structural
context of mutations that cause congenital myasthenic syndrome (CMS). The
domain scaffold (strands and loops) is shown in blue with the Ca2+ atom in
white whilst the missense mutations positions (numbering referring to human
agrin, NCBI code: O00468) are reported in purple. The model was constructed
using the perlecan LG3 domain (PDB: 3SH5; see Figure 2) as a template.
recognition of another disaccharide unit, thus strengthening the
interaction between α-DG and these LG domains including slit-
2 (see below); the stacking interaction between R2803 and the
carbohydrate Xyl2 sugar ring in the laminin-a2 LG4 structure
co-crystallized with a LARGE polysaccharide unit (Briggs et al.,
2016) provides a possible context for this type of interaction
(see Figure 3).
The proposed structural basis for binding of slit-2 to α-DG
is additionally supported by the observation that the Ca2+-
binding edge of the domain can be modeled to interact with
a disaccharide moiety in a manner similar to that identified
in the structure of laminin-α2 LG4 co-crystallized with a
polysaccharide moiety (Briggs et al., 2016) (i.e., very similar
to the structure of perlecan LG overlaid with the disaccharide
shown in Figure 3). Comparison of the equivalent LG models
of slit-1 and slit-3 (Figure 8) indicates (a) that slit-3 is predicted
to have a “weaker” binding site for Ca2+, although it has
a KVR sequence in the same location as that of slit-2, and
(b) that slit-1 lacks the KVR sequence and thus may have a
weaker interaction with DG compared to slit-2. In addition,
slit-3 lacks the highly conserved glycine residue (G1222 in
slit-2; G2826 in murine laminin α2 LG4; G4276 in perlecan,
see Figure 3; this Gly residue is underlined in Table 2) that
may be important for maintaining structure near the Ca2+
binding site.
A VISUALIZATION CODE FOR BINDING
AFFINITIES OF LG DOMAINS
TOWARD α-DG
The binding affinities of recombinantly expressed LG domains
from several DG binding partners have classically been
measured or estimated by semi-quantitative solid-phase
binding assays or by more quantitative Surface Plasmon
Resonance. In some cases, very high apparent affinities
(Kd’s within the range 0.1–1 nM) have been reported
(for a comprehensive review, see Sciandra et al., 2013).
Data from these studies have allowed us to construct a
scheme to characterize α-DG binding of LG domains
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FIGURE 8 | Potential Ca2+ sites of the LG domains of the three Slits: (A) Slit-1; (B) Slit-2; (C) Slit-3. Models were built on templates of LG domains with known
structures (see main text) and viewed from the top edge of the β-sandwich (where “top” is equivalent to the upper part of the LG domain structures as represented in
Figure 2). Slit-2 has a similar arrangement of potential Ca2+-chelating groups (red), as perlecan (see Figure 2). In isoforms 2 and 3 the KVR sequence (basic residues
in purple) that supports α-DG binding is adjacent to the Ca2+ site; for comparison, the basic KSRK sequence that hinders α-DG binding in the agrin LG2 splice
variant (see Figure 6) would lie to the right of the Ca2+ binding site in this view.
FIGURE 9 | A color code for LG domain-α-dystroglycan binding affinities. Based on available biochemical information, the α-DG binding partners are classified by the
binding affinities of their multiple LG domains, represented using the color code reported in the figure. The affinity scale has been estimated semi-quantitatively based
on available binding data (see Sciandra et al., 2013): tighter affinity refers to the lower nanomolar range (0.1–1 nM), medium affinity to the higher nanomolar range
(10–100 nM), weak or very weak binding within the micromolar range. The laminin (LN) sub-family (referring to the five different α chains, A1 to A5) is on the left whilst
agrin (AGR), perlecan (PRL) and other binding partners (PKC: pikachurin, NRX: neurexin, SLT2: Slit-2) are on the right. The drawings are not to scale. Numbers
between domains indicate the number of amino acids in the linkers separating them.
according to the affinity and requirements for multiple LG
domains (Figure 9).
It is evident that a tandem array of 2 or 3 LG domains in a row
is often required for strong α-DG binding (brown in Figure 9),
and these combinations (a doublet in laminin-α2; a triplet in
perlecan) constitute the tightest binding detected to date. Orange
and red both indicate a reduced but still significant affinity.
Importantly, the few domains that apparently bind α-DG in an
isolated fashion do so with relatively high affinity (see also below).
However, these are not universal properties: LG3 of laminin-α2
can bind but with a weaker affinity, and tandem combinations of
laminin-α4 (LG1-3 and LG4-5) and laminin-α5 (LG4-5) show a
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weaker binding than the tandem LGs noted above. Amongst the
laminins, laminin-α3 LG domains stand out as having negligible
affinity for α-DG.
Overall, it appears that the LG assembly that most favors α-
DG binding is one formed by at least two sequential LG domains.
Such an assembly can be found in the LG4-5 of laminins α1,
α2, α4, and α5, in agrin (LG1-2) and pikachurin (LG2-3); tight
or moderate binding by a three LG-domains array is found in
laminin-α2 and α4 as well as in perlecan (LG1-3). Overall, the
tandem arrays found in laminin-α2 (skeletal muscle isoform) and
perlecan (expressed at the neuromuscular junction, NMJ) show
the tightest binding to dystroglycan. This is in accordance with
the biological importance of the DG adhesion complex for the
stability of adult skeletal muscle and of the post-synaptic element
within the peripheral nervous system (i.e., at the NMJ). Only in
a limited number of cases (reported in red in Figure 9) does an
isolated LG bind strongly. These include LG4 of laminin-α1, LG4
of laminin-α5, LG2, and LG6 of neurexin1α, LG1 of neurexin1β
(which has an identical sequence to LG6 of neurexin1α) and
LG1 of slit2.
ARE THERE UNIVERSAL STRUCTURAL
FEATURES IN LG DOMAINS THAT
PREDICT THEIR PROPENSITY TO
BIND α-DYSTROGLYCAN?
Ca2+ Coordination
As described above, the typical LG module comprises a compact
sandwich in which 2 β-sheets (formed by 7 β-strands each)
pack against each other, and all LG domains of known structure
contain a conserved Ca2+ coordination site. Since LG domains
function in the relatively high Ca2+ concentration of the
extracellular matrix, their Ca2+ binding affinity is very weak in
comparison with intracellular proteins that chelate Ca2+ strongly
such as calmodulin (4 acidic Ca2+-coordinating side chains, with
Kd’s within the range of 1–0.01µM, Linse et al., 1991), and is
likely to be more similar to that of the sarcoplasmic reticulum
Ca2+ binder calsequestrin, for example, whose Ca2+-binding
sites contain only one or two acidic groups and whose Kd is in
the millimolar range (Sanchez et al., 2012).
In the two examples of LG domains for which structures with
and without Ca2+ are known (agrin and perlecan), the Ca2+
binding site is essentially pre-formed (Figure 5A), indicating that
Ca2+ binding is not required for the overall fold of the LG
domain. This contrasts with very tight Ca2+ binders involved
in Ca2+-induced allosteric regulation, such as calmodulin, in
which structure is induced in a disordered Ca2+-free binding
site when Ca2+ binds. However, NMR studies on perlecan LG
domains indicate that Ca2+ binding, although not stringently
required for correct folding, stabilizes the LG domain structure
(Le et al., 2011). Although the Ca2+ site in all LG domains is
at best a weak binding site and includes only one or two acidic
side chain calcium-chelating ligands (see Table 2), LG domains
known to lack α-DG binding activitymay be especially poor Ca2+
binders. Homology models of the laminin-α3 LG domains, for
example, indicate that the groups putatively responsible for Ca2+
coordination, located at the edge of the LG domain constitute a
far from ideal set of potential Ca2+-chelators (Figure 5B).
Linear α-DG-Binding Module(s)
It is expected that those LG domains able to bind α-DG as
single domains may display some relevant sequence features
that would be necessary for α-DG binding, and likewise, that
useful information might be retrieved by comparative analysis
of those domains which are reported not to bind α-DG. For this
reason, we performed a series of alignments of selected protein
sequences, with reference to human sequences. The alignment of
so-called “isolated binders” is reported in Figure 10, and the LG
domains of laminin-α3, which does not bind α-DG, are examined
in Figure 11. An alignment of all the LG sequences under
consideration was also made (Figure S1). Although perlecan
domains have not been reported to bind α-DG in isolation
(Friedrich et al., 1999; Talts et al., 1999), the sequence of human
perlecan LG3 domain has also been included in the alignments
in order to compare all the human sequences within a typical
LG-domain secondary structure framework.
Based on the alignment in Figure 10, no universal short
linear DG-binding motif(s) can be identified, and it is likely
that a combination of sequence and structural features is
required. The laminin α2 LG4 LARGE carbohydrate crystal
structure (Briggs et al., 2016) shows that hydrogen bond
interactions between the LG domain and carbohydrate sugar
rings involve backbone amide groups (Figure 3) and these
potentially important interactions may be rather relaxed with
respect to amino acid sequence requirements and therefore not
apparent in searches for sequence homologies. It is notable that
the J strand is less conserved in the binders (Figure 10) compared
to non-binders (Figure 11) and, overall, the J strand appears to
be the least conserved within the entire LG domain β-strand-
scaffold. In contrast to other strands, none of the residues of the J
strand are highlighted in black or gray, indicating a high degree of
amino acid variability (see Figure S1). This variability could play
a functional role, for example in modulating α-DG recognition.
Recurring Basic Residues Within Specific
Structural Elements
The presence of scattered patches of basic residues in and
around the Ca2+ cleft of LG domains has been suggested to
represent an important requirement for α-DG binding (Harrison
et al., 2007). Mutation to alanine of the two basic residues
within the KVR sequence on the B-C loop of slit-2 (Wright
et al., 2012) and the topologically-equivalent RKR (to AKA)
in laminin-α1 LG4 (Harrison et al., 2007) abolishes α-DG
binding. These observations are consistent with the expectation
that basic residues facilitate the binding of LG domains to the
negatively charged carbohydrate groups on α-DG. Although
there were some notable discrepancies between the data collected
by Harrison et al. (2007) and earlier mutational analysis from
Andac et al. (1999), that might be ascribed to differences in the
experimental conditions used and/or source of α-dystroglycan
samples (see Harrison et al., 2007), the emerging scenario
indicates that the basic residues whose mutation most perturbs
α-DG binding fall on the edge of the domain that contains the
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FIGURE 10 | Multiple sequence alignment of selected isolated LG domains that are binders of α-DG. The sequences refer to all the strong binders identified and
include also the LG3 module of the laminin α2 chain (reported to be a weaker binder). Secondary structure elements, as retrieved from the available 3D structure of
human perlecan (3SH4/3SH5), are rendered as follows: β-strands, from A to N (red), α-helices (purple), calcium-coordinating amino acid positions (orange and
indicated by an asterisk). Sequences were aligned in MUSCLE 3.8 and the alignment presented in Boxshade. Basic residues belonging to the loops neighboring the
coordinated Ca2+ are reported in blue, the ones belonging to the opposite side of the domain are turquoise. The specific LG domain sequences in the alignment are
identified as follows: NRX1A/1B: neurexin α1/β1, LNA1/2/5: laminin α1/α2/α5, SLT2: slit-2, PRL: perlecan.
Ca2+-binding site (Figure 2), as expected for a role in binding
to carbohydrate groups on α-DG. This observation, however, is
not easily generalized to the whole family of LG domains which,
whether binders or non-binders, have little overall net charge at
physiological pH (see Table S1).
The sequence relationships of LG domains were also
investigated by molecular phylogeny. The phylogenetic diagram
resulting from the multiple sequence alignment showed the
LN3-LG1 domain to be distinct from the other sequences
analyzed, forming a separate branch in the tree. Within
the other clades and sub-clades, there was no discrete
segregation of known α-DG-binding LG domains from non-
binders (Figure 12, asterisks indicate known α-DG-binding
LG domains). Although this analysis is limited to the subset
of experimentally-tested LG domains, the results indicate
that there are no clear sequence features that distinguish α-
DG binding domains from non-binders in this set, pointing
to an apparent paradox intrinsic to the very nature of
LG domains.
Thus, the identified features that modulate DG binding
affinity, namely the presence and “strength” of the Ca2+ binding
site and the presence of KVK-like basic patches, despite being
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FIGURE 11 | Multiple sequence alignment of selected isolated LG domains that are non-binders of α-DG. Laminin α3 has been reported not to bind α-DG. Therefore,
it is assumed that none of its tandem LG domains would be able to bind α-DG. Secondary structure elements as retrieved from the available 3D structure of human
perlecan (3SH4/3SH5): β-strands, from A to N (red), α-helices (purple), calcium-coordinating amino acid positions (orange and indicated by an asterisk). Basic
residues belonging to the loops neighboring the coordinated Ca2+ are reported in blue whereas the one belonging to the opposite side of the domain in turquoise.
Code: LNA3_LG1 to LNA3_LG5 (1st to 5th module from laminin α3).
predictive of a possible interaction, cannot alone distinguish
unequivocally between strong, weak, or non-binders of α-DG.
IS AFFINITY REGULATED
BY MODULARITY?
Extending the analysis beyond single LG domains, tandem
arrays of LG domains might constitute a way to modulate
binding affinity toward α-DG through modular binding
to its glycan scaffold. Indeed, the glycan polymer of α-
DG has been defined as a tunable extracellular matrix
protein scaffold for which increasing chain length during
myogenesis enhances ligand-binding capacity (Goddeeris
et al., 2013; Yoshida-Moriguchi and Campbell, 2015). Are
multiple, tandem LG domains required for binding partners
to recognize a series of disaccharide units on α-DG (termed
matriglycan) (Willer et al., 2014)? Such a multiple binding
mode could be a mechanism to increase the overall affinity
between α-DG and LG domains in vivo (Figure 13). As a
matter of fact, regulation of affinity through multivalency is
a widely accepted concept in the lectin-carbohydrate field
(Raman et al., 2005).
It is interesting to note that two LG domains that can act as
isolated binders, (in red in inset to Figure 13), have not been
found next to each other in any of the DG-binding proteins.
It is tempting to propose that the assembly of repeated tight
DG-binding LG domains would make the binding too strong
to be compatible with normal physiology. Instead, the tandem
assembly as well as the modularity of LG domains of different
binding affinities could be a way to tune the interaction between
α-DG and its binding partners (Figure 13). This notion could
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be helpful for the design of therapeutic laminin- or agrin-
based molecules.
It is also unclear whether the presence of tandem arrays of LG
domains may be important to favor their folding and stability or
FIGURE 12 | Unrooted phylogenetic diagram of the protein sequence
relationships of the LG domains analyzed in this study. The alignment of 246
positions was prepared in MAFFT and the Newick output rendered in iTOL.
Codenames as in Table 1. Asterisks indicate known α-DG-binding LG
domains.
is strictly necessary to achieve a physiologically relevant affinity
toward α-DG. This is an important question and further work
will be required in order to address it properly.
The presence of short basic motifs (KVR or similar) in the
loop between the B and C strands of LG domains could be
a factor to strengthen the affinity toward α-DG in binding
partners possessing only one LG domain, such as slit-2. Another
protein with only one LG domain is neurexin1β, which, as
a presynaptic protein, might require a relatively tight binding
affinity to recognize carbohydrate moieties protruding into the
synaptic cleft from the postsynaptically-located α-DG. In this
regard, it should be noted that the longer neurexins-α have
LG domains which are able to bind DG in an isolated fashion
(LG2 and LG6). However, the KVR motif does not appear to
be conserved in neurexins (Figure 10), thus other factors could
be involved. The fine regulation of the affinities between DG
and these neuronal proteins may make important contributions
in the central nervous system for the stability of synaptic
elements (Hunter et al., 2017) and/or for neuronal pathfinding
(Wright et al., 2012).
The polysaccharide polymer that protrudes from α-DG
represents a scaffold with multiple attachment sites for ECM
binding partners. In skeletal muscle, where α-DG is extensively
glycosylated, it has been suggested that this glycan scaffold
would act to prevent muscular dystrophy (Goddeeris et al.,
2013; Yoshida-Moriguchi and Campbell, 2015). Nevertheless, it
is tempting to speculate that too tight an interaction between
α-DG and laminin-α2 could also be potentially dangerous for
skeletal muscle physiology as it could impair some necessary
conformational plasticity (implying a dynamic behavior based
on cycles of fast attachment/detachment/re-attachment) at
the interface between the sarcolemma of muscle fibers and
FIGURE 13 | LG-domains binding modes toward α-DG. Model of how different tandem assembly combinations might be required for fine modulation of α-DG binding
affinity. The distance between the two disaccharide units that interact with two adjacent LG domains has not been determined, and the cartoon only depicts an
example scenario. Because of their size, tandem LG domains cannot bind to adjacent GlcA-Xyl disaccharide units. A disaccharide unit is indicated, with Xyl: Xylose
and GlucA: Glucuronic acid. The grouping on the right illustrates that LG domains that are able to bind α-DG as isolated units (in red) have not been found as
neighbors. For color code, see Figure 9.
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the surrounding basement membranes. The presence of a
limited amount of LG domains, with a distinctively tight
binding affinity for α-DG, could favor such modulation, tuning
the affinity of laminin for α-DG to an optimal degree for
muscle physiology.
FUTURE PERSPECTIVE: BIOMEDICAL
SIGNIFICANCE OF DIFFERENTIAL LG
DOMAIN AFFINITIES
TOWARD α-DYSTROGLYCAN
The importance of studying the molecular mechanism(s) that
regulate the affinity between α-DG and its binding partners is
emphasized by the frequent use of laminin isoforms in gene-
therapy approaches. For example, laminin-111 (containing the
α1 chain) (Gawlik et al., 2010) as well as a miniaturized version
of agrin (the so-called mini-agrin) (Moll et al., 2001), have
been proposed as candidates for rescuing the severe congenital
muscular dystrophy phenotypes in which laminin-211 is absent.
Both of these contain LG domains known to interact strongly
with α-DG. Recently, the crucial role played by the affinity of
different binding partners toward α-DG has been highlighted
by the finding that within the embryonic heart, agrin muscle
isoform (A0B0), instead of laminin-2, is the preferential α-DG
binder. During development, agrin binding to α-DG promotes
the release of the transcription factor YAP (yes-associated protein
1) from sequestration by the dystrophin-glycoprotein complex
(Morikawa et al., 2017), eventually allowing YAP to reach the
nucleus and trigger the regeneration of cardiac myofibers (Bassat
et al., 2017). Therefore, through a deeper knowledge of the
molecular basis of LG domain affinity toward α-DG, strategies
to modulate these interactions may be developed, and further
therapeutic avenues for the treatment of severe neuromuscular
disorders or for triggering regeneration procedures in the adult
myocardium could be explored (Eroglu and Chien, 2017).
DATA AVAILABILITY
The authors declare that all data generated for this study are
included in the manuscript and the Supplementary Files.
AUTHOR CONTRIBUTIONS
MGB andAB conceived the project. CD performed themodeling.
JA performed the tree analysis. AB carried out the sequence
alignment analysis. CD, MGB, JA, and AB analyzed the data. CD
and AB wrote the paper. All authors reviewed and contributed to
the various draft versions of the manuscript. All authors read and
approved the final manuscript.
FUNDING
MGB was supported by a Wellcome Trust Career Re-entry
Fellowship, Ref. n. 097350/Z/11/Z.
ACKNOWLEDGMENTS
The School of Biochemistry (University of Bristol) is gratefully
acknowledged for hosting AB.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fmolb.
2019.00018/full#supplementary-material
REFERENCES
Adams, J. C., and Brancaccio, A. (2015). The evolution of the dystroglycan
complex, a major mediator of muscle integrity. Biol. Open. 4, 1163–1179.
doi: 10.1242/bio.012468
Adams, J. C., and Lawler, J. (2011). The thrombospondins. Cold
Spring Harb. Perspect. Biol. 3:a009712. doi: 10.1101/cshperspect.a0
09712
Andac, Z., Sasaki, T., Mann, K., Brancaccio, A., Deutzmann, R., and Timpl, R.
(1999). Analysis of heparin, α-dystroglycan and sulfatide binding to the G
domain of the laminin α1 chain by site-directed mutagenesis. J. Mol. Biol. 287,
253–264. doi: 10.1006/jmbi.1999.2606
Barresi, R., and Campbell, K. P. (2006). Dystroglycan: from biosynthesis to
pathogenesis of human disease. J. Cell Sci. 119, 199–207. doi: 10.1242/jcs.02814
Bassat, E., Mutlak, Y. E., Genzelinakh, A., Shadrin, I. Y., Baruch Umansky,
K., Yifa, O., et al. (2017). The extracellular matrix protein agrin promotes
heart regeneration in mice. Nature 547, 179–184. doi: 10.1038/nature
22978
Beck, K., Hunter, I., and Engel, J. (1990). Structure and function of
laminin: anatomy of a multidomain glycoprotein. FASEB J. 4, 148–160.
doi: 10.1096/fasebj.4.2.2404817
Bozic, D., Sciandra, F., Lamba, D., and Brancaccio, A. (2004). The structure
of the N-terminal region of murine skeletal muscle α-dystroglycan
discloses a modular architecture. J. Biol. Chem. 279, 44812–44816.
doi: 10.1074/jbc.C400353200
Brancaccio, A., Schulthess, T., Gesemann, M., and Engel, J. (1995). Electron
microscopic evidence for a mucin-like region in chick muscle α-dystroglycan.
FEBS Lett. 368, 139–142. doi: 10.1016/0014-5793(95)00628-M
Briggs, D. C., Yoshida-Moriguchi, T., Zheng, T., Venzke, D., Anderson, M. E., and
Strazzulli, A. (2016). Structural basis of laminin binding to the LARGE glycans
on dystroglycan. Nat. Chem. Biol. 12, 810–814. doi: 10.1038/nchembio.2146
Campanelli, J. T., Gayer, G. G., and Scheller, R. H. (1996). Alternative RNA splicing
that determines agrin activity regulates binding to heparin and α-dystroglycan.
Development 122, 1663–1672.
Carafoli, F., Clout, N. J., and Hohenester, E. (2009). Crystal structure of the
LG1-3 region of the laminin α2 chain. J. Biol. Chem. 284, 22786–22792.
doi: 10.1074/jbc.M109.026658
Carulli, S., Beck, K., Dayan, G., Boulesteix, S., Lortat-Jacob, H., and Rousselle,
P. (2012). Cell surface proteoglycans syndecan-1 and -4 bind overlapping
but distinct sites in laminin α3 LG45 protein domain. J. Biol. Chem. 287,
12204–12216. doi: 10.1074/jbc.M111.300061
Chen, F., Venugopal, V., Murray, B., and Rudenko, G. (2011). The structure of
neurexin 1α reveals features promoting a role as synaptic organizer. Structure
19, 779–789. doi: 10.1016/j.str.2011.03.012
Durbeej, M., Talts, J. F., Henry, M. D., Yurchenco, P. D., Campbell, K. P., and
Ekblom, P. (2001). Dystroglycan binding to laminin α1LG4 module influences
epithelial morphogenesis of salivary gland and lung in vitro. Differentiation 69,
121–134. doi: 10.1046/j.1432-0436.2001.690206.x
Eroglu, E., and Chien, K. R. (2017). Heart regeneration 4.0: matrix medicine. Dev.
Cell. 42, 7–8. doi: 10.1016/j.devcel.2017.06.017
Frontiers in Molecular Biosciences | www.frontiersin.org 17 March 2019 | Volume 6 | Article 18
Dempsey et al. α-Dystroglycan/Binding to LG Domains
Ervasti, J. M., and Campbell, K. P. (1993). A role for the dystrophin-glycoprotein
complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122,
809–823. doi: 10.1083/jcb.122.4.809
Ferletta, M., Kikkawa, Y., Yu, H., Talts, J. F., Durbeej, M., Sonnenberg, A.,
et al. (2003). Opposing roles of integrin α6Aβ1 and dystroglycan in laminin-
mediated extracellular signal-regulated kinase activation. Mol. Biol. Cell. 14,
2088–2103. doi: 10.1091/mbc.e03-01-0852
Friedrich, M. V., Göhring, W., Mörgelin, M., Brancaccio, A., David, G., and
Timpl, R. (1999). Structural basis of glycosaminoglycan modification and of
heterotypic interactions of perlecan domain V. J Mol Biol. 294, 259–270.
doi: 10.1006/jmbi.1999.3259
Gawlik, K. I., Akerlund, M., Carmignac, V., Elamaa, H., and Durbeej, M.
(2010). Distinct roles for laminin globular domains in laminin α1 chain
mediated rescue of murine laminin α2 chain deficiency. PLoS ONE 5:e11549.
doi: 10.1371/journal.pone.0011549
Gesemann, M., Brancaccio, A., Schumacher, B., and Ruegg, M. A. (1998). Agrin
is a high-affinity binding protein of dystroglycan in non-muscle tissue. J. Biol.
Chem. 273, 600–605. doi: 10.1074/jbc.273.1.600
Gesemann, M., Cavalli, V., Denzer, A. J., Brancaccio, A., Schumacher, B., and
Ruegg, M. A. (1996). Alternative splicing of agrin alters its binding to
heparin, dystroglycan, and the putative agrin receptor. Neuron 16, 755–767.
doi: 10.1016/S0896-6273(00)80096-3
Goddeeris, M. M., Wu, B., Venzke, D., Yoshida-Moriguchi, T., Saito, F.,
and Matsumura, K. (2013). LARGE glycans on dystroglycan function as
a tunable matrix scaffold to prevent dystrophy. Nature 503, 136–140.
doi: 10.1038/nature12605
Gonzalez, E. M., Reed, C. C., Bix, G., Fu, J., Zhang, Y., Gopalakrishnan, B.,
et al. (2005). BMP-1/Tolloid-like metalloproteases process endorepellin, the
angiostatic C-terminal fragment of perlecan. J. Biol. Chem. 280, 7080–7087.
doi: 10.1074/jbc.M409841200
Harrison, D., Hussain, S. A., Combs, A. C., Ervasti, J. M., Yurchenco,
P. D., and Hohenester, E. (2007). Crystal structure and cell surface
anchorage sites of laminin α1LG4-5. J. Biol. Chem. 282, 11573–11581.
doi: 10.1074/jbc.M610657200
Hofer, A. M., and Brown, E. M. (2003). Extracellular calcium sensing and
signalling. Nat. Rev. Mol. Cell Biol. 4, 530–538. doi: 10.1038/nrm1154
Hohenester, E., Tisi, D., Talts, J. F., and Timpl, R. (1999). The crystal
structure of a laminin G-like module reveals the molecular basis of α-
dystroglycan binding to laminins, perlecan, and agrin. Mol. Cell. 4, 783–792.
doi: 10.1016/S1097-2765(00)80388-3
Hopf, C., and Hoch, W. (1996). Agrin binding to α-dystroglycan. Domains of
agrin necessary to induce acetylcholine receptor clustering are overlapping
but not identical to the α-dystroglycan-binding region. J. Biol. Chem. 271,
5231–5236.
Hunter, D. D., Manglapus, M. K., Bachay, G., Claudepierre, T., Dolan, M. W.,
Gesuelli, K. A., et al. (2017). CNS synapses are stabilized trans-synaptically
by laminins and laminin-interacting proteins. J. Comp. Neurol. 527, 67–86.
doi: 10.1002/cne.24338
Huzé C., Bauché S., Richard, P., Chevessier, F., Goillot, E., Gaudon, K.,
et al. (2009). Identification of an agrin mutation that causes congenital
myasthenia and affects synapse function. Am. J. Hum. Genet. 85, 155–167.
doi: 10.1016/j.ajhg.2009.06.015
Hynes, R. O. (2012). The evolution of metazoan extracellular matrix. J. Cell Biol.
196, 671–679. doi: 10.1083/jcb.201109041
Ido, H., Harada, K., Futaki, S., Hayashi, Y., Nishiuchi, R., Natsuka, Y., et al. (2004).
Molecular dissection of the α-dystroglycan- and integrin-binding sites within
the globular domain of human laminin-10. J. Biol. Chem. 279, 10946–10954.
doi: 10.1074/jbc.M313626200
Kanagawa, M., Omori, Y., Sato, S., Kobayashi, K., Miyagoe-Suzuki, Y., Takeda,
S., et al. (2010). Post-translational maturation of dystroglycan is necessary
for pikachurin binding and ribbon synaptic localization. J. Biol. Chem. 285,
31208–31216. doi: 10.1074/jbc.M110.116343
Kanagawa, M., and Toda, T. (2018). Ribitol-phosphate-a newly identified
posttranslational glycosylation unit in mammals: structure, modification
enzymes and relationship to human diseases. J. Biochem. 163, 359–369.
doi: 10.1093/jb/mvy020
Karakaya, M., Ceyhan-Birsoy, O., Beggs, A. H., and Topaloglu, H. (2017).
A novel missense variant in the AGRN gene; congenital myasthenic
syndrome presenting with head drop. J. Clin. Neuromuscul. Dis. 18, 147–151.
doi: 10.1097/CND.0000000000000132
Kikkawa, Y., Yu, H., Genersch, E., Sanzen, N., Sekiguchi, K., Fässler, R.,
et al. (2004). Laminin isoforms differentially regulate adhesion, spreading,
proliferation, and ERK activation of β1 integrin-null cells. Exp. Cell Res. 300,
94–108. doi: 10.1016/j.yexcr.2004.06.031
Le, B. V., Kim, H., Choi, J., Kim, J. H., Hahn, M. J., Lee, C., et al. (2011). Crystal
structure of the LG3 domain of endorepellin, an angiogenesis inhibitor. J. Mol.
Biol. 414, 231–242. doi: 10.1016/j.jmb.2011.09.048
Linse, S., Helmersson, A., and Forsen, S. (1991). Calcium binding to calmodulin
and its globular domains. J. Biol. Chem. 266, 8050–8054.
Manya, H., and Endo, T. (2017). Glycosylation with ribitol-phosphate inmammals:
new insights into the O-mannosyl glycan. Biochim. Biophys. Acta Gen. Subj.
1861, 2462–2472. doi: 10.1016/j.bbagen.2017.06.024
Maselli, R. A., Fernandez, J. M., Arredondo, J., Navarro, C., Ngo, M., Beeson,
D., et al. (2012). LG2 agrin mutation causing severe congenital myasthenic
syndrome mimics functional characteristics of non-neural (z-) agrin. Hum.
Genet. 131, 1123–1135. doi: 10.1007/s00439-011-1132-4
McDearmon, E. L., Combs, A. C., Sekiguchi, K., Fujiwara, H., and Ervasti,
J. M. (2006). Brain α-dystroglycan displays unique glycoepitopes and
preferential binding to laminin-10/11. FEBS Lett. 580, 3381–3385.
doi: 10.1016/j.febslet.2006.05.010
Missler, M., Fernandez-Chacon, R., and Südhof, T. C. (1998).
The making of neurexins. J. Neurochem. 71, 1339–1347.
doi: 10.1046/j.1471-4159.1998.71041339.x
Moll, J., Barzaghi, P., Lin, S., Bezakova, G., Lochmüller, H., Engvall, E., et al.
(2001). An agrin minigene rescues dystrophic symptoms in a mouse model for
congenital muscular dystrophy. Nature 413, 302–307. doi: 10.1038/35095054
Morikawa, Y., Heallen, T., Leach, J., Xiao, Y., and Martin, J. F. (2017). Dystrophin-
glycoprotein complex sequesters Yap to inhibit cardiomyocyte proliferation.
Nature 547, 227–231. doi: 10.1038/nature22979
Omori, Y., Araki, F., Chaya, T., Kajimura, N., Irie, S., Terada, K., et al. (2012).
Presynaptic dystroglycan-pikachurin complex regulates the proper synaptic
connection between retinal photoreceptor and bipolar cells. J. Neurosci. 32,
6126–6137. doi: 10.1523/JNEUROSCI.0322-12.2012
O’Toole, J. J., Deyst, K. A., Bowe, M. A., Nastuk, M. A., McKechnie, B. A., and
Fallon, J. R. (1996). Alternative splicing of agrin regulates its binding to heparin
α-dystroglycan, and the cell surface. Proc. Natl. Acad. Sci. U.S.A. 93, 7369–7374.
doi: 10.1073/pnas.93.14.7369
Özbek, S., Balasubramainian P, Chiquet-Ehrismann, R., Tucker, R. P., and Adams,
J. C. (2010). The evolution of extracellular matrix.Mol. Biol. Cell 21, 4300–4306.
doi: 10.1091/mbc.e10-03-0251
Raman, R., Raguram, S., Venkataraman, G., Paulson, J. C., and Sasisekharan,
R. (2005). Glycomics: an integrated systems approach to structure-function
relationships of glycans. Nat Methods. 2, 817–824. doi: 10.1038/nmeth807
Reissner, C., Stahn, J., Breuer, D., Klose, M., Pohlentz, G., Mormann,
M., et al. (2014). Dystroglycan binding to α-neurexin competes with
neurexophilin-1 and neuroligin in the brain. J. Biol. Chem. 289, 27585–27603.
doi: 10.1074/jbc.M114.595413
Rudenko, G. (2017). Dynamic control of synaptic adhesion and
organizing molecules in synaptic plasticity. Neural. Plast. 2017:6526151.
doi: 10.1155/2017/6526151
Rudenko, G., Hohenester, E., and Muller, Y. A. (2001). LG/LNS domains:
multiple functions – one business end? Trends Biochem. Sci. 26, 363–368.
doi: 10.1016/S0968-0004(01)01832-1
Rudenko, G., Nguyen, T., Chelliah, Y., Südhof, T. C., and Deisenhofer,
J. (1999). The structure of the ligand-binding domain of neurexin Iβ:
regulation of LNS domain function by alternative splicing. Cell 99, 93–101.
doi: 10.1016/S0092-8674(00)80065-3
Ruegg, M. A., and Bixby, J. L. (1998). Agrin orchestrates synaptic differentiation
at the vertebrate neuromuscular junction. Trends Neurosci. 21, 22–27.
doi: 10.1016/S0166-2236(97)01154-5
Sallum, C. O., Kammerer, R. A., and Alexandrescu, A. T. (2007). Thermodynamic
and structural studies of carbohydrate binding by the agrin-G3 domain.
Biochemistry 46, 9541–9550. doi: 10.1021/bi7006383
Sanchez, E. J., Lewis, K. M., Danna, B. R., and Kang, C. (2012). High-capacity
Ca2+ binding of human skeletal calsequestrin. J. Biol. Chem. 287, 11592–11601.
doi: 10.1074/jbc.M111.335075
Frontiers in Molecular Biosciences | www.frontiersin.org 18 March 2019 | Volume 6 | Article 18
Dempsey et al. α-Dystroglycan/Binding to LG Domains
Sato, S., Omori, Y., Katoh, K., Kondo, M., Kanagawa, M., Miyata, K., et al. (2008).
Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse
formation. Nat. Neurosci. 11, 923–931. doi: 10.1038/nn.2160
Sciandra, F., Bozzi, M., Bigotti, M. G., and Brancaccio, A. (2013). The
multiple affinities of α-dystroglycan. Curr. Protein Pept. Sci. 14, 626–634.
doi: 10.2174/1389203711209070644
Sheckler, L. R., Henry, L., Sugita, S., Südhof, T. C., and Rudenko, G. (2006).
Crystal structure of the second LNS/LG domain from neurexin 1α: Ca2+
binding and the effects of alternative splicing. J. Biol. Chem. 281, 22896–22905.
doi: 10.1074/jbc.M603464200
Sheikh, M. O., Halmo, S. M., and Wells, L. (2017). Recent advancements
in understanding mammalian O-mannosylation. Glycobiology 27, 806–819.
doi: 10.1093/glycob/cwx062
Shen, K. C., Kuczynska, D. A., Wu, I. J., Murray, B. H., Sheckler, L. R.,
and Rudenko, G. (2008). Regulation of neurexin 1β tertiary structure
and ligand binding through alternative splicing. Structure 16, 422–431.
doi: 10.1016/j.str.2008.01.005
Shimizu, H., Hosokawa, H., Ninomiya, H., Miner, J. H., and Masaki, T. (1999).
Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by
dystroglycan. J. Biol. Chem. 274, 11995–12000. doi: 10.1074/jbc.274.17.11995
Stetefeld, J., Alexandrescu, A. T., Maciejewski, M. W., Jenny, M., Rathgeb-Szabo,
K., Schulthess, T., et al. (2004). Modulation of agrin function by alternative
splicing andCa2+ binding. Structure 12, 503–515. doi: 10.1016/j.str.2004.02.001
Südhof, T. C. (2008). Neuroligins and neurexins link synaptic function to cognitive
disease. Nature 455, 903–911. doi: 10.1038/nature07456
Sugita, S., Saito, F., Tang, J., Satz, J., Campbell, K., and Südhof, T. C. (2001). A
stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol. 154,
435–445. doi: 10.1083/jcb.200105003
Suzuki, N., Nakatsuka, H., Mochizuki, M., Nishi, N., Kadoya, Y., Utani,
A., et al. (2003). Biological activities of homologous loop regions in
the laminin alpha chain G domains. J. Biol. Chem. 278, 45697–45705.
doi: 10.1074/jbc.M304667200
Talts, J. F., Andac, Z., Göhring,W., Brancaccio, A., and Timpl, R. (1999). Binding of
the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides,
α-dystroglycan and several extracellular matrix proteins. EMBO J. 18, 863–870.
doi: 10.1093/emboj/18.4.863
Talts, J. F., Mann, K., Yamada, Y., and Timpl, R. (1998). Structural analysis and
proteolytic processing of recombinant G domain of mouse laminin α2 chain.
FEBS Lett. 426, 71–76. doi: 10.1016/S0014-5793(98)00312-3
Talts, J. F., Sasaki, T., Miosge, N., Göhring, W., Mann, K., Mayne, R., et al.
(2000). Structural and functional analysis of the recombinant G domain of the
laminin α4 chain and its proteolytic processing in tissues. J. Biol. Chem. 275,
35192–35199. doi: 10.1074/jbc.M003261200
Talts, J. F., and Timpl, R. (1999). Mutation of a basic sequence in
the laminin α2LG3 module leads to a lack of proteolytic processing
and has different effects on β1 integrin-mediated cell adhesion and α-
dystroglycan binding. FEBS Lett. 1999, 319–323. doi: 10.1016/S0014-5793(99)0
1180-1
Timpl, R., Tisi, D., Talts, J. F., Andac, Z., Sasaki, T., and Hohenester, E. (2000).
Structure and function of laminin LG modules. Matrix Biol. 19, 309–317.
doi: 10.1016/S0945-053X(00)00072-X
Tisi, D., Talts, J. F., Timpl, R., and Hohenester, E. (2000). Structure of the C-
terminal laminin G-like domain pair of the laminin α2 chain harbouring
binding sites for α-dystroglycan and heparin. EMBO J. 19, 1432–1440.
doi: 10.1093/emboj/19.7.1432
Utani, A., Nomizu, M., Matsuura, H., Kato, K., Kobayashi, T., Takeda, U., et al.
(2001). A unique sequence of the laminin α3G domain binds to heparin
and promotes cell adhesion through syndecan-2 and -4. J. Biol. Chem. 276,
28779–28788. doi: 10.1074/jbc.M101420200
Willer, T., Inamori, K., Venzke, D., Harvey, C., Morgensen, G., Hara, Y.,
et al. (2014). The glucuronyltransferase B4GAT1 is required for initiation
of LARGE-mediated α-dystroglycan functional glycosylation. Elife 3:e03941.
doi: 10.7554/eLife.03941
Wizemann, H., Garbe, J. H., Friedrich, M. V., Timpl, R., Sasaki, T., andHohenester,
E. (2003). Distinct requirements for heparin and α-dystroglycan binding
revealed by structure-based mutagenesis of the laminin α2 LG4-LG5 domain
pair. J. Mol. Biol. 332, 635–642. doi: 10.1016/S0022-2836(03)00848-9
Wright, K. M., Lyon, K. A., Leung, H., Leahy, D. J., Ma, L., and Ginty, D. D. (2012).
Dystroglycan organizes axon guidance cue localization and axonal pathfinding.
Neuron 76, 931–944. doi: 10.1016/j.neuron.2012.10.009
Xi, J., Yan, C., Liu, W. W., Qiao, K., Lin, J., Tian, X., et al. (2017). Novel SEA and
LG2 Agrin mutations causing congenital Myasthenic syndrome. Orphanet. J.
Rare Dis. 12:182. doi: 10.1186/s13023-017-0732-z
Yokoyama, F., Suzuki, N., Kadoya, Y., Utani, A., Nakatsuka, H., Nishi, N., et al.
(2005). Bifunctional peptides derived from homologous loop regions in the
laminin α chain LG4modules interact with both α2β1 integrin and syndecan-2.
Biochemistry 44, 9581–9589. doi: 10.1021/bi050598t
Yoshida-Moriguchi, T., and Campbell, K. P. (2015). Matriglycan: a novel
polysaccharide that links dystroglycan to the basement membrane.
Glycobiology 25, 702–713. doi: 10.1093/glycob/cwv021
Yu, H., and Talts, J. F. (2003). β1 Integrin and α-dystroglycan binding sites are
localized to different laminin-G-domain-like (LG) modules within the laminin
α5 chain G domain. Biochem. J. 371, 289–299. doi: 10.1042/bj20021500
Zhang, Y., Dai, Y., Han, J. N., Chen, Z. H., Ling, L., Pu, C. Q., et al. (2017). A novel
AGRNmutation leads to congenital myasthenic syndrome only affecting limb-
girdle muscle. Chin. Med. J. 130, 2279–2282. doi: 10.4103/0366-6999.215332
Zhou, Y. W., Thomason, D. B., Gullberg, D., and Jarrett, H. W. (2006).
Binding of laminin α1-chain LG4-5 domain to α-dystroglycan causes tyrosine
phosphorylation of syntrophin to initiate Rac1 signaling. Biochemistry 45,
2042–2052. doi: 10.1021/bi0519957
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Dempsey, Bigotti, Adams and Brancaccio. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Molecular Biosciences | www.frontiersin.org 19 March 2019 | Volume 6 | Article 18
